Melissa Glasner: The Safe and Effective Implementation of FXI/XIa Inhibitors Into Clinical Practice
Melissa Glasner, Medical Content Manager at The France Foundation, shared on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH, adding:
”I am very pleased to announce the publication of the first of three manuscripts by the ISTH FXI/XIa Steering Committee.
As FXI/XIa inhibitors move closer to clinical practice, this review highlights the critical role of laboratory testing, assay standardization, and multidisciplinary collaboration in supporting their safe and effective implementation.
Thank you to my co-authors, especially Dave Gailani and Jeffrey Weitz, for their assistance, guidance, and mentorship throughout the development of this manuscript.
A special shout-out, as always, to Miriam Giles for keeping us organized during the submission and peer review process – couldn’t have done it without you!”
Title: Measuring up: the need for new assays for factor (F)XI/FXIa inhibitor therapies
Authors: Melissa F. Glasner, David Gailani, Rasha Al-Lamee, María Cecilia Bahit, Jonathan Coutinho, Clay Johnston, Wolfgang C. Winkelmayer, Jeffrey Weitz
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period